Effekten af Adductor-Kanal-Blokade (AKB) hos patienter efter knæ-artroskopiThe Effect of Adductor-Canal-Blockade (ACB) in Patients After Knee Arthroscopy

Conditions: Patients who have had a artroscopic investigation of the knee. We want to investigate wheather Ropivacain can be used as a postoperative analgetic drug, when applied ultrasound-guided as a nerve block in the adductor Canal. This could be an alternative method for postoperative analgeisa with less side-effects than i.v.-administrated opioid/neuroaxial blockade.
MedDRA version: 12.1Level: LLTClassification code 10036236Term: Postoperative pain relief
MedDRA version: 12.1Level: LLTClassification code 10054711Term: Postoperative pain

Registration Number: EUCTR2010-022849-19-DK

Lead Sponsor: Professor Jørgen B. Dahl

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Recruiting

Sex: All

Target Recruitment: Not specified

Inclusion Criteria

18-80 years of age
Surgery in general anesthesia
ASA-group I-III
BMI 19-35
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients who can not co-operate (e.g. dementia)
Patients who do not speak danish
Allergic reaktions toward drugs used in the trial
Abuse of alcohol/other drugs
Patients who can not be mobilised
Pregnant women
Skin-infektion close to the injection site

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary end point(s): VAS-score 2 hours post surgery, patient standing;Main Objective: Pain/VAS-score, patient standing, 2 hours postoperative;Secondary Objective: Pain/VAS-score at rest at different times during the first 24 hours after surgery<br>Pain/VAS-score standing/when mobilised and after 5 meters walk at different times 24 hours after surgery<br>postoperative opioid-consumption (24 hours)<br>Postoperative nausea/vomiting (24 hours) <br>Postoperative sedation (24 hours)

Secondary Outcome Measures